<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03411642</url>
  </required_header>
  <id_info>
    <org_study_id>PV5225</org_study_id>
    <nct_id>NCT03411642</nct_id>
  </id_info>
  <brief_title>Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke</brief_title>
  <acronym>CONTEST</acronym>
  <official_title>Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Albertinen-Krankenhaus Hamburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regio Klinikum Pinneberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helios University Hospital Wuppertal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kreiskliniken Reutlingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Karlsbad-Langensteinbach</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Comparative Effectiveness Study of Transthoracic and Transesophageal Echocardiography in
      Stroke (CONTEST) aims at assessing the diagnostic value of transesophageal echocardiography
      (TEE) and transthoracic echocardiography (TTE) with regards to treatment consequences in
      patients with acute ischemic stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For this purpose, the investigators will perform a prospective multicenter diagnostic
      comparative effectiveness study. Patients with acute stroke will be studied by both TTE and
      TEE. Patients with already defined stroke etiology and determined secondary prevention will
      be excluded from the trial. Treatment relevant diagnostic findings will be identified by a
      central endpoint adjudication committee. In order to demonstrate a hypothesized 2% absolute
      increase in the number of treatment relevant diagnostic findings by TEE as compared to TTE,
      880 stroke patients will be enrolled in six German stroke centers. CONTEST will allow
      answering the question whether and for which group of stroke patients TEE is indicated in
      addition to TTE. By this, the study will provide evidence to guide justified recommendations
      for echocardiography in acute stroke patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Actual">August 31, 2019</completion_date>
  <primary_completion_date type="Actual">June 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of diagnostic findings that lead to a change in acute treatment or treatment for secondary prevention</measure>
    <time_frame>Baseline</time_frame>
    <description>Treatment relevant diagnostic findings will be identified by a central endpoint adjudication committee comprising both cardiologists and neurologists.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of other major or minor risk factors for cardiac embolism detected by TTE or TEE.</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">517</enrollment>
  <condition>Stroke, Acute</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute stroke in whom echocardiography is indicated will be studied by TTE and
        TEE.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  acute ischemic stroke or transitory ischemic attack (TIA)

          -  age ≥18 years

          -  informed consent

        Exclusion Criteria:

          -  Patients with already defined stroke etiology and determined secondary prevention
             treatment strategy prior to echocardiography (e.g. atrial fibrillation, carotid artery
             stenosis, cervical artery dissection)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Götz Thomalla, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albertinen-Krankenhaus</name>
      <address>
        <city>Hamburg</city>
        <zip>22457</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regio Klinikum Pinneberg</name>
      <address>
        <city>Pinneberg</city>
        <zip>25421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskliniken Reutlingen</name>
      <address>
        <city>Reutlingen</city>
        <zip>72764</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>January 19, 2018</study_first_submitted>
  <study_first_submitted_qc>January 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2018</study_first_posted>
  <last_update_submitted>September 26, 2019</last_update_submitted>
  <last_update_submitted_qc>September 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke, echocardiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

